14 win spots on DISA's $7.5B SETI contract

Fourteen companies have won places on the full-and-open piece of the $7.5 billion "SETI" contract for systems engineering services to the Defense Information Services Agency.

Fourteen companies have won positions on the full-and-open portion of a potential 10-year, $7.5 billion contract for systems engineering and technical services to the Defense Information Services Agency.

DISA received 35 total bids for this unrestricted piece of the Systems Engineering, Technology and Innovation contract vehicle also known as “SETI.” The Defense Department said in its Thursday awards digest that DISA will separately award the small business track at a later date.

SETI is a brand new requirement and was awarded on a best-value tradeoff basis. The contract is intended as a more flexible and innovative, higher-end complement to DISA’s $17.5 billion Encore 3 commodity IT services vehicle that was awarded as low-price, technically acceptable.

Awardees for SETI are:

  • AASKI Technology
  • Accenture Federal Services
  • BAE Systems Inc.
  • Booz Allen Hamilton
  • Deloitte
  • IBM
  • KeyW Corp.
  • Leidos
  • Linquest
  • NES Associates (acquired by CSRA, which is now part of General Dynamics)
  • Northrop Grumman
  • Parsons
  • Peraton
  • Vencore (now part of Perspecta)

AASKI, Booz Allen, Leidos and General Dynamics through its CSRA acquisition are on both SETI and Encore 3. The SETI contract has a five-year base period followed by a single five-year option.

DISA originally intended to award no more than 10 contracts for SETI’s unrestricted portion and 20 for the small business track with one reserved for a HUBZone company, according to the February 2017 solicitation for bids.

SETI awardees will vie for work in task areas such as systems engineering, design analysis engineering, systems architecture, software systems design and development, systems integration, systems test and evaluation, systems deployment and lifecycle engineering, and special systems engineering requirements.

NEXT STORY: Dive into the 2018 Top 100